An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
2 Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, Liverpool, United Kingdom.
3 Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
1 Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
2 Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, Liverpool, United Kingdom.
3 Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Conflicts of Interest: SLH: received research funding from Bristol-Myers Squibb (BMS), outside of the submitted work. SPJ: Consultant for BMS/Pfizer. Institutional research funding from BMS/Pfizer, outside the submitted work. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthem. No fees are received personally. SPJ and GYHL are co-principal investigators of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899871.
Figures
Figure 1
Extension of the Atrial Fibrillation…
Figure 1
Extension of the Atrial Fibrillation Better Care (ABC) pathway to include consideration of…
Figure 1
Extension of the Atrial Fibrillation Better Care (ABC) pathway to include consideration of screening for pre-frailty and frailty in the “C” component of the pathway.